Thrombosis with Thrombocytopenia Syndrome (TTS) is a rare condition associated with the AstraZeneca COVID-19 vaccine

Share News that unites, stories that inspire!

Tweet

Thrombosis with Thrombocytopenia Syndrome (TTS) is a rare condition associated with the AstraZeneca COVID-19 vaccine. It occurs when a person experiences blood clots (thrombosis) along with a low platelet count (thrombocytopenia).

Here are the symptoms of Thrombosis with Thrombocytopenia Syndrome TTS:

1. Brain Involvement:
   • Severe, persistent headache
   • Blurred vision
   • Difficulty speaking
   • Drowsiness
   • Seizures or confusion
2. Other Body Symptoms:
   • Difficulty breathing
   • Chest pain
   • Leg swelling
   • Persistent abdominal (stomach) pain
   • Tiny blood spots under the skin, away from the site of injection

These Thrombosis with Thrombocytopenia Syndrome symptoms typically occur between 4 and 42 days after receiving the AstraZeneca COVID-19 vaccine. Early recognition and treatment are crucial for managing TTS effectively. If a clot in the brain is suspected, patients should seek urgent medical attention.

Thrombosis with Thrombocytopenia Syndrome (TTS) remains a topic of intense investigation. Here’s what we know so far:

1. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT):
   • Scientists first identified this condition in March 2021.
   • It occurs when a person develops both a blood clot (thrombosis) and an extremely low platelet count (thrombocytopenia).
   • VITT is a rare side effect of COVID-19 vaccination, but it requires urgent medical care when it occurs.
2. Thrombosis with Thrombocytopenia Syndrome Symptoms to Watch For:
   • If you experience any of the following symptoms 4 to 42 days after vaccination, seek immediate medical attention:
     • Chest pain
     • Headache lasting more than 48 hours after vaccination or appearing later than 48 hours after vaccination, accompanied by nausea and vomiting
     • Blurred vision
     • Drowsiness
     • Seizures or confusion
     • Difficulty speaking
     • Trouble breathing
     • Tiny blood spots under the skin (petechiae), not near the injection site
     • Persistent abdominal pain
     • Swelling in the leg
3. Causal Mechanism Unclear for Thrombosis with Thrombocytopenia Syndrome:
   • The exact mechanism that causes TTS after COVID-19 vaccination is not yet fully understood.
   • Adenovirus-based vaccines (such as AstraZeneca and Janssen) are more likely to be associated with TTS than injectable mRNA vaccines (Moderna or Pfizer).
4. Risk and Benefit Balance:
   • While TTS is a serious concern, the overall risk of developing it after vaccination remains extremely low.
   • The risk of severe outcomes from COVID-19 itself far outweighs the risk of TTS related to COVID-19 vaccines.

Thrombosis with Thrombocytopenia Syndrome

As research continues, vigilance, transparency, and informed decision-making are crucial to ensuring public health and safety.

More Articles

Choosing Healthy Diet Breads for Optimal Health

Revolutionizing Breast Cancer Care: Antidiabetic Drug Boosts Immunity, Battles Cancer